Palatin Q1 FY2024 net loss narrows to $5.9M; Vyleesi revenue up 142% YoY

PALATIN TECHNOLOGIES INC

Net loss per share $(0.48) vs $(0.86) YoY; Vyleesi net revenue $2.1M, +142% YoY.
Phase 3 DED study (PL9643) fully enrolled (n=570); topline data expected late Q4 2023.
Phase 2 oral PL8177 in ulcerative colitis interim analysis targeted Q1 2024.
Vyleesi gross sales $4.6M (+11% vs prior quarter); 7th consecutive quarter double-digit growth.
Cash $5.5M at Sept 30; plus $4.5M net from October offering; expects cash into H1 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

PALATIN TECHNOLOGIES INC reported financial results for fiscal first quarter ended September 30, 2023.

Period: fiscal first quarter ended September 30, 2023
Result: reported results

Exact text from the filing

On November 14, 2023, we issued a press release including results for our quarter ended September 30, 2023, and announcing a teleconference and webcast to be held November 14, 2023, at 11:00 a.m. Eastern time, which will include a discussion on results of operations in greater detail and an update on corporate developments.

View on SEC.gov

Browse all earnings releases →

PALATIN TECHNOLOGIES INC filing history →

Source: SEC EDGAR

accession 0001654954-23-014239

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.